VINC

Companies
NASDAQ
Vincerx Pharma Inc.
Health Care
Price Chart
Overview

About VINC

vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.

Market Cap
$21.0M
Volume
24.8K
Avg. Volume
68.5K
P/E Ratio
-0.8104477
Dividend Yield
0.00%
Employees
24.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.59
Low Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for VINC.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, VINC shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$21.0M
Volume24.8K
P/E Ratio-0.81
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 28, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how VINC fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025